Prospective Observational Post-Marketing Study of Tafluprost for Glaucoma and Ocular Hypertension: Effectiveness and Treatment Persistence.

about

The clinical effectiveness of tafluprost on Japanese normal-tension glaucoma patients.

P2860

Q51733198-787B6BC4-D114-416D-AEF4-D5FA4E9C0616

P2860

Prospective Observational Post-Marketing Study of Tafluprost for Glaucoma and Ocular Hypertension: Effectiveness and Treatment Persistence.

Item

http://www.wikidata.org/entity/Q38787393

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Prospective Observational Post ...... ess and Treatment Persistence.

@en

type

Item

label

Prospective Observational Post ...... ess and Treatment Persistence.

@en

prefLabel

Prospective Observational Post ...... ess and Treatment Persistence.

@en

P1476

Prospective Observational Post ...... ess and Treatment Persistence.

@en

P2093

Akio Nomura

http://www.w3.org/2001/XMLSchema#string

Fumiki Shimada

http://www.w3.org/2001/XMLSchema#string

Masako Hashimoto

http://www.w3.org/2001/XMLSchema#string

Reiko Kakegawa

http://www.w3.org/2001/XMLSchema#string

Yasuaki Kuwayama

http://www.w3.org/2001/XMLSchema#string

P2860

Persistency and treatment failure in newly diagnosed open angle glaucoma patients in the United Kingdom

Persistency with medical treatment for glaucoma and ocular hypertension in the United Kingdom: 1994-2005.

Long-term outcomes of prostaglandin analog versus timolol maleate in ocular hypertensive or primary open-angle glaucoma patients in Europe.

The impact of ocular adverse effects in patients treated with topical prostaglandin analogs: changes in prescription patterns and patient persistence.

Prospective observational post-marketing study of tafluprost for glaucoma and ocular hypertension: short-term efficacy and safety.

Persistence and adherence with topical glaucoma therapy.

Persistence of glaucoma medical therapy in the Glasgow Glaucoma Database.

A randomized, 36-month, post-marketing efficacy and tolerability study in Sweden and Finland of latanoprost versus non-prostaglandin therapy in patients with glaucoma or ocular hypertension.

Eyelid and eyelash changes due to prostaglandin analog therapy in unilateral treatment cases.

Nonresponders to Prostaglandin Analogs Among Normal-Tension Glaucoma Patients.

P2888

s12325-017-0549-0

P304

1411-1425

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12325-017-0549-0

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1085402167

http://www.w3.org/2001/XMLSchema#string

P698

28502035

http://www.w3.org/2001/XMLSchema#string

Prospective Observational Post-Marketing Study of Tafluprost for Glaucoma and Ocular Hypertension: Effectiveness and Treatment Persistence.

about

P2860

P2860

Prospective Observational Post-Marketing Study of Tafluprost for Glaucoma and Ocular Hypertension: Effectiveness and Treatment Persistence.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P6179

P698